COOPER GLENN L MD Insider Trading
Get the latest insider transactions of COOPER GLENN L MD. COOPER GLENN L MD is President and CEO in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in REPLIGEN CORP ($RGEN). Discover the current value of COOPER GLENN L MD shares.
Address: INDEVUS PHARMACEUTICALS, INC. 99 HAYDEN AVENUE LEXINGTON 02421MA
COOPER GLENN L MD is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| IDEV | Endo Pharmaceuticals Solutions Inc. | President and CEO | 185,000 | 0.00 |
| RGEN | REPLIGEN CORP | Director | 35,975 | 1,051,909.00 |
Insider Trading Transactions of COOPER GLENN L MD
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| May 28 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Sell | 66.91 | 4,734 | 316,752 | 35,975 |
| May 28 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Sell | 67.53 | 266 | 17,963 | 35,709 |
| May 17 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Buy | 0.00 | 923 | 0 | 40,709 |
| May 17 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | 67.71 | 2,109 | 142,800 | 2,109 |
| May 17 2018 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Buy | 0.00 | 1,486 | 0 | 39,786 |
| May 17 2018 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | 42.07 | 3,304 | 138,999 | 3,304 |
| May 22 2017 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Buy | 0.00 | 1,206 | 0 | 38,300 |
| May 22 2017 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | 38.76 | 2,434 | 94,342 | 2,434 |
| May 13 2016 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Buy | 0.00 | 1,763 | 0 | 37,094 |
| May 13 2016 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | 26.12 | 3,366 | 87,920 | 3,366 |
| Nov 12 2015 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Buy | 26.56 | 1,000 | 26,564 | 35,331 |
| May 26 2015 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Buy | 0.00 | 1,019 | 0 | 34,331 |
| May 26 2015 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | 41.19 | 1,992 | 82,050 | 1,992 |
| Mar 11 2005 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 3.70 | 75,000 | 277,500 | 75,000 |
| Feb 16 2005 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Buy | 4.05 | 10,000 | 40,500 | 185,000 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 4.16 | 300,000 | 1,248,000 | 0 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 4.16 | 300,000 | 1,248,000 | 300,000 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 6.19 | 800,000 | 4,952,000 | 0 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 6.19 | 800,000 | 4,952,000 | 800,000 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 4.16 | 60,000 | 249,600 | 0 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 4.16 | 60,000 | 249,600 | 60,000 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 5.00 | 60,000 | 300,000 | 0 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 5.00 | 60,000 | 300,000 | 60,000 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 4.16 | 300,000 | 1,248,000 | 0 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 4.16 | 300,000 | 1,248,000 | 300,000 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 6.19 | 800,000 | 4,952,000 | 0 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 6.19 | 800,000 | 4,952,000 | 800,000 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 4.16 | 60,000 | 249,600 | 0 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 4.16 | 60,000 | 249,600 | 60,000 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 5.00 | 60,000 | 300,000 | 0 |
| Sep 16 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 5.00 | 60,000 | 300,000 | 60,000 |
| Mar 12 2004 | IDEV | Endo Pharmaceuticals Solu ... | COOPER GLENN L MD | President and CEO | Option Exercise | 5.92 | 150,000 | 888,000 | 150,000 |